Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Telomere repeats at chromosomal ends, critical for genomic integrity, undergo age‐dependent attrition and telomere length has been associated with different disorders including cancers. In this study, based on 1469 patients and 1158 healthy controls, we show a statistically significant (P = 6 × 10−10) association between increased telomere length and melanoma risk. Mendelian randomization, using 5 telomere length‐associated polymorphisms, ruled out confounding factors or reverse causality and showed association between increased telomere length and melanoma risk with odds ratio of 2.66 (95% confidence interval: 2.07‐3.25). Age‐dependent telomere attrition was faster in melanoma cases than controls (P = .01). The carriers of a highly penetrant germline ‐57A>C TERT promoter mutation, in a previously reported melanoma family, had longer telomeres than the noncarriers. The mutation causes increased TERT and telomerase levels through creation of a binding motif for E‐twenty six (ETS) transcription factors and the carriers develop melanoma with an early age of onset and rapid progression to metastasis. In analogy, we hypothesize that increased telomere length in melanoma patients reflects stochastic increased telomerase levels due to common genetic variation. Paradoxically, we observed shorter telomeres (P = 1 × 10−5) in primary tumors from unrelated melanoma patients with (121) than without (170) somatic TERT promoter mutations that similar to the germline mutation, also create binding motifs for ETS transcription factors. However, the age‐dependent telomere attrition was faster in tumors with the TERT promoter mutations than in those without such mutations. Besides a robust association between increased telomere length and risk, our data show a perturbed telomere homeostasis in melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“Telomeres in general, due to excessive proliferation or through other disruptions like shelterin complex dysregulation, are shorter in tumors than in noncancerous tissues as observed in this study.(42) Despite rejuvenated telomerase in most instances, cancers due to functional constraints maintain short telomeres.”
BackgroundVariation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 6×
“Our data from the melanoma family with the -57A>C germline TERT promoter mutation exemplifies a severe case for the role of long constitutive telomeres in cancer disposition that would be in consonant with the two hit model of telomere length paradox.(16) The germline mutation predisposes the carriers to an early onse…”
BackgroundMethodResultInfluentialSelf-citationBlackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Barthel, F. P., Wei, W., Tang, M., Martinez-Ledesma, E., Hu, X., Amin, S. B., Akdemir, K. C., Seth, S., Song, X., Wang, Q., et al. (2017) · Nature Genetics · doi:10.1038/ng.3781 · Cited by 614
Broer, L., Codd, V., Nyholt, D. R., Deelen, J., Mangino, M., Willemsen, G., Albrecht, E., Amin, N., Beekman, M., de Geus, E. J. C., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.303 · Cited by 450
Common variants near TERC are associated with mean telomere length
Wellcome Trust Case Control Consortium, Codd, V., Mangino, M., van der Harst, P., Braund, P. S., Kaiser, M., Beveridge, A. J., Rafelt, S., Moore, J., Nelson, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.532 · Cited by 344
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238
Self-citationOxidative guanine base damage regulates human telomerase activity
Fouquerel, E., Lormand, J., Bose, A., Lee, H.-T., Kim, G. S., Li, J., Sobol, R. W., Freudenthal, B. D., Myong, S., & Opresko, P. L. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3319 · Cited by 182
Cited by
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 304
Self-citationKroupa, M., Rachakonda, S. K., Liska, V., Srinivas, N., Urbanova, M., Jiraskova, K., Schneiderova, M., Vycital, O., Vymetalkova, V., Vodickova, L., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0525-3 · Cited by 41
Self-citationWang, P., Hu, L., Fu, G., Lu, J., Zheng, Y., Li, Y., & Jia, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s249348 · Cited by 29
Metadata
- Authors
- Rachakonda, S., Kong, H., Srinivas, N., Garcia‐Casado, Z., Requena, C., Fallah, M., Heidenreich, B., Planelles, D., Traves, V., Schadendorf, D., Nagore, E., & Kumar, R.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2018-09-11
- Volume
- 57
- Issue
- 11
- Pages
- 564-572
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2889982462
- Cited by
- 51
- References
- 9
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk. https://app.cochat.ai/papers/10.1002/gcc.22669
- The paper
- Rachakonda, S., Kong, H., Srinivas, N., Garcia‐Casado, Z., Requena, C., Fallah, M., Heidenreich, B., Planelles, D., Traves, V., Schadendorf, D., Nagore, E., & Kumar, R. (2018). Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.22669
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.